Management and technology consulting company Booz Allen (BAH) is set to release its Fiscal Q4 2025 earnings report later this week. That may have some investors wondering if now is the right time to buy BAH shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
When weighing a potential investment in BAH stock, the first thing traders will want to consider is its potential. That includes Wall Street’s estimates for its upcoming earnings report. Analysts expect Booz Allen to report adjusted earnings per share of $1.61 on revenue of $3.03 billion. These would represent 21.05% in EPS growth and a 9.39% increase in revenue year-over-year.
The next thing for traders to analyze is how likely Booz Allen is to beat these estimates. Based on the company’s earnings history, it’s chances are high. The consulting firm has beat Wall Street’s EPS estimates in six of the last eight quarters and surpassed revenue estimates in all eight of them. If that trend continues in Fiscal Q4 2025, it could be a positive catalyst for BAH stock.
Recent BAH Stock Analyst Coverage
Analysts have also started updating their coverage of Booz Allen ahead of the company’s earnings report. That starts with UBS analyst Gavin Parsons’ reiterated Hold rating. However, the analyst increased his price target for BAH stock from $120 to $135 per share, representing a potential 4.33%. More analyst updates will likely be revealed leading up to and following the release of the company’s earnings report.
BAH stock was down 0.34% on Wednesday, but remains up 0.9% year-to-date. The stock has also dropped 15.49% over the past year.
Is BAH Stock a Buy, Sell, or Hold?
Turning to Wall Street, the analysts’ consensus rating for Booz Allen is Moderate Buy, based on four Buy, four Hold, and one Sell ratings over the last three months. With that comes an average BAH stock price target of $136.89, representing a potential 5.91% upside for the shares.
